Compare YTRA & RCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | YTRA | RCEL |
|---|---|---|
| Founded | 2005 | N/A |
| Country | India | United States |
| Employees | N/A | N/A |
| Industry | Transportation Services | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 113.1M | 102.5M |
| IPO Year | N/A | N/A |
| Metric | YTRA | RCEL |
|---|---|---|
| Price | $1.50 | $3.99 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 4 |
| Target Price | $3.00 | ★ $7.17 |
| AVG Volume (30 Days) | 110.4K | ★ 233.5K |
| Earning Date | 02-11-2026 | 02-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.01 | N/A |
| Revenue | ★ $114,229,876.00 | $72,401,000.00 |
| Revenue This Year | N/A | $13.61 |
| Revenue Next Year | $6.62 | $19.61 |
| P/E Ratio | $218.38 | ★ N/A |
| Revenue Growth | ★ 82.82 | 20.59 |
| 52 Week Low | $0.58 | $3.22 |
| 52 Week High | $2.00 | $11.25 |
| Indicator | YTRA | RCEL |
|---|---|---|
| Relative Strength Index (RSI) | 37.14 | 48.51 |
| Support Level | $1.38 | $3.87 |
| Resistance Level | $1.70 | $4.56 |
| Average True Range (ATR) | 0.10 | 0.25 |
| MACD | -0.03 | -0.04 |
| Stochastic Oscillator | 18.42 | 27.47 |
Yatra Online Inc is an Indian consumer travel platform provider and online travel agent. The company is organized into the following business segments; Air Ticketing which derives maximum revenue, Hotels and Packages, and Other Services. It mainly provides travel-related services, which include domestic and international air ticketing, hotel bookings, homestays, holiday packages, bus ticketing, rail ticketing, activities and ancillary services. It also involves hosting advertisements on its internet websites, the sale of rail and bus tickets, and facilitating website access to travel insurance companies. Some of its applications include Yatra Mini, Yatra Web Check-In, Yatra Corporate, and Travelguru HomeStay.
Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently in rollout across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.